abarelix: Clinical Trials

3 trials of abarelix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 suspended. 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1
Phase 41Suspended 1

Follow abarelix: new trials by email Literature Review of abarelix trials Research Report on abarelix

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Plenaxis® Experience Study
Plenaxis - Prostate Cancer
Phase 4SuspendedPRAECIS Pharmaceuticals Inc.20002004-06-012006-09-19
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
Plenaxis - Prostate Cancer
Phase 2CompletedPRAECIS Pharmaceuticals Inc.222004-05-012006-09-19
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Abarelix, Goserelin plus Bicalutamide - Prostate Cancer
Phase 3CompletedSpeciality European Pharma Limited1771999-01-012009-02-11

Conditions studied

Prostatic Neoplasms (3)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Sponsors

PRAECIS Pharmaceuticals Inc. (2)  ·  Speciality European Pharma Limited (1)

Countries

United States (2)

Top investigators

Frans M J Debruyne, MD (1)  ·  Gerald Riedel, PhD (1)  ·  Marc Garnick, MD (1)